New York State Common Retirement Fund Sells 254,500 Shares of OrthoPediatrics Corp. $KIDS

New York State Common Retirement Fund reduced its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 57.1% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 191,066 shares of the company’s stock after selling 254,500 shares during the quarter. New York State Common Retirement Fund’s holdings in OrthoPediatrics were worth $3,540,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of KIDS. Los Angeles Capital Management LLC bought a new stake in OrthoPediatrics in the second quarter valued at approximately $220,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of OrthoPediatrics by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company’s stock valued at $246,000 after buying an additional 645 shares during the period. R Squared Ltd bought a new stake in shares of OrthoPediatrics in the 2nd quarter valued at $272,000. Connor Clark & Lunn Investment Management Ltd. raised its stake in OrthoPediatrics by 12.4% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 15,901 shares of the company’s stock worth $342,000 after buying an additional 1,753 shares during the period. Finally, Jane Street Group LLC acquired a new stake in OrthoPediatrics during the 1st quarter worth $389,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

OrthoPediatrics Stock Performance

Shares of KIDS stock opened at $16.65 on Friday. The company has a debt-to-equity ratio of 0.28, a current ratio of 7.40 and a quick ratio of 3.52. OrthoPediatrics Corp. has a one year low of $15.28 and a one year high of $26.40. The company has a fifty day moving average price of $17.91 and a two-hundred day moving average price of $18.53. The stock has a market cap of $417.58 million, a P/E ratio of -8.54 and a beta of 1.12.

Wall Street Analysts Forecast Growth

KIDS has been the topic of a number of research analyst reports. BTIG Research reaffirmed a “buy” rating and set a $23.00 price target on shares of OrthoPediatrics in a research report on Wednesday, October 29th. TD Cowen upgraded shares of OrthoPediatrics to a “strong-buy” rating in a report on Tuesday, January 27th. Canaccord Genuity Group initiated coverage on shares of OrthoPediatrics in a report on Wednesday, December 10th. They issued a “buy” rating and a $24.00 price target for the company. Weiss Ratings restated a “sell (e+)” rating on shares of OrthoPediatrics in a report on Thursday, January 22nd. Finally, Needham & Company LLC cut their price objective on shares of OrthoPediatrics from $42.00 to $26.00 and set a “buy” rating on the stock in a research report on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, OrthoPediatrics has a consensus rating of “Moderate Buy” and an average target price of $23.89.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.